The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Plaque inhibition assay for drug susceptibility testing of influenza viruses
Open accessAbstract
The relative antiviral activities of four drugs against contemporary strains of influenza A and B viruses were determined in Madin-Darby canine kidney cell monolayers with a plaque inhibition assay. This assay proved to be a reliable, rapid method of determining 50% inhibitory concentrations that correlated well with clinically achievable drug levels and the results of clinical trials. Contemporary strains of influenza A viruses (subtypes H1N1, H3N2, HSW1N1) required amantadine hydrochloride and rimantadine hydrochloride 50% inhibitory concentrations in the range of 0.2 to 0.4 microgram/ml, whereas 50% inhibitory concentrations ranged from approximately 50 to 100 micrograms/ml against influenza B viruses. Ribavirin was approximately 10-fold less active than amantadine hydrochloride against influenza A viruses, and the ribavirin 50% inhibitory concentrations against both influenza A and B viruses ranged from 2.6 to 6.8 micrograms/ml. Inosiplex had no antiviral activity in this test system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tobita, K., Sugiura, A., Enomoto, C., & Furuyama, M. (1975) · Medical Microbiology and Immunology · doi:10.1007/bf02123572 · Cited by 406
Wingfield, W. L., Pollack, D., & Grunert, R. R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909112811102 · Cited by 234
Rifampicin inhibits the Growth of Some Mammalian Viruses
SUBAK-SHARPE, J. H., TIMBURY, M. C., & WILLIAMS, J. F. (1969) · Nature · doi:10.1038/222341a0 · Cited by 163
Prevention of Russian Influenza by Amantadine
Monto, A. S. (1979) · JAMA · doi:10.1001/jama.1979.03290360019018 · Cited by 125
Magnussen, C. R., Douglas, R. G., Betts, R. F., Roth, F. K., & Meagher, M. P. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.4.498 · Cited by 68
Self-citationEvaluation of Amantadine in Artificially Induced A2 and B Influenza
Smorodintsev, A. A. (1970) · JAMA · doi:10.1001/jama.1970.03170350016003 · Cited by 54
Schulman, J. L. (1968) · Experimental Biology and Medicine · doi:10.3181/00379727-128-33222 · Cited by 36
Antiviral activity of oxidized polyamines and aldehydes
Kremzner, L. T., & Harter, D. H. (1970) · Biochemical Pharmacology · doi:10.1016/0006-2952(70)90002-x · Cited by 22
Cited by
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., Tai, C. Y., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963036t · Cited by 1,100
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
Furuta, Y., Takahashi, K., Fukuda, Y., Kuno, M., Kamiyama, T., Kozaki, K., Nomura, N., Egawa, H., Minami, S., Watanabe, Y., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.977-981.2002 · Cited by 501
Drug resistance in influenza A virus: the epidemiology and management
Hussain, M., Galvin, H., Haw, T. Y., Nutsford, A., & Husain, M. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s105473 · Cited by 439
Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus
Gubareva, L. V., Matrosovich, M. N., Brenner, M. K., Bethell, R. C., & Webster, R. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/314440 · Cited by 432
Metadata
- Authors
- Hayden, F. G., Cote, K. M., & Douglas, R. G.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1980-05
- Volume
- 17
- Issue
- 5
- Pages
- 865-870
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2036015085
- Cited by
- 278
- References
- 8
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.